Non-Small Cell Lung Cancer (NSCLC) Treatment in United Arab Emirates
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Non-Small Cell Lung Cancer (NSCLC)?
About 85% of all instances of lung cancer are non-small cell lung cancer (NSCLC), making it the most common kind of the disease. It happens when aberrant cells proliferate in the lungs and cause tumors to grow. Compared to small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) is typically less aggressive and grows and spreads more slowly.
Type of Non-Small Cell Lung Cancer (NSCLC)
There are many types of NSCLC, including-
- Adenocarcinoma: It typically develops in the outer parts of the lungs and is the most common type of lung cancer.
- Squamous Cell Carcinoma: Usually starts in the central part of the lungs and is often associated with a smoking history.
- Large Cell Carcinoma: It can develop in any part of the lungs and is prone to grow and spread quickly
What is the Importance of Timely Treatment?
Timely treatment of Non-Small Cell Lung Cancer (NSCLC) is essential for several reasons:
- Improved Prognosis: With surgery or localised radiotherapy, early-stage NSCLC can frequently be successfully treated, increasing the chance of long-term survival. Early detection increases the likelihood of the cancer being successfully treated and having a favorable outcome.
- Prevents Spread: If treatment is not received, non-small cell lung cancer (NSCLC) can spread (metastasise) to other body areas, including the brain, liver, and bones, making treatment more difficult and decreasing the likelihood of survival.
- Treatment Effectiveness: More treatment options, such as surgical resection or targeted medicines, are available with an early diagnosis; these alternatives may become less effective as the cancer progresses.
- Minimizes Complications: The likelihood of consequences, including lung collapse, breathing problems, or fluid accumulation, which might occur as the cancer worsens, is decreased with prompt treatment.
- Better Quality of Life: Early cancer detection can improve symptom management and help people live better while undergoing treatment and recuperating.
What are the Common Symptoms of Non-Small Cell Lung Cancer (NSCLC)?
Respiratory Symptoms
- Persistent Cough
- Shortness of Breath
- Coughing Up Blood
- Wheezing
Chest Symptoms
- Chest Pain
- Hoarseness
General Symptoms
- Loss of Appetite
- Unexplained Weight Loss
- Fatigue
- Frequent Infections such as bronchitis or pneumonia
Causes and risk factors of Non-Small Cell Lung Cancer (NSCLC)?
Causes
- Genetic alterations that lead to changes in the DNA of lung cells cause the uncontrolled expression of genes and ultimately cause cancer.
- Prolonged exposure to certain chemicals and toxins may increase the risk factor of developing NSCLC cancer.
Risk Factors
- Smoking tobacco
- Environmental exposures like radon, Asbestos and air pollution, exposure of some workplace chemicals like formaldehyde, arsenic, and benzene.
- Family history of lung cancer
- Older age above 60-80 years
- Having respiratory conditions like pulmonary fibrosis.
- Previous radiation therapy for the breast and chest
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Non-Small Cell Lung Cancer (NSCLC) in the United Arab Emirates
Through immunotherapies, targeted medicines, innovative research, advanced technologies, and interdisciplinary approaches, non-small cell lung cancer (NSCLC) treatment has advanced significantly in the United Arab Emirates (UAE). Prominent medical facilities provide all-encompassing care, including modern therapies like immunotherapy and stereotactic ablative radiation (SABR) and sophisticated diagnostic instruments like low-dose computed tomography (LDCT) for early identification. Additionally, biotech companies are creating localised drug delivery devices like the MediChip to maximise the effectiveness of chemotherapy while reducing systemic side effects.
Non-Small Cell Lung Cancer (NSCLC) Prevention Tips
There are a few things you can do to lower your risk of developing Non-Small Cell Lung Cancer (NSCLC), particularly of the bladder, even if it is not always preventable:
- Avoid smoking
- Avoid second hand smoke
- Limit exposure to carcinogens like radon, asbestos, and arsenic.
- Maintain a healthy lifestyle by improving lifestyle modifications such as eating a well-balanced diet, exercising regularly to improve lung function, and maintaining a sleep-wake cycle to support the immune system.
- Early genetic counseling shall be considered; screening can help identify genetic mutations and guide preventive measures.
- Reduce exposure to air pollution
- Protect Yourself from Occupational Hazards
Treatment options for Non-Small Cell Lung Cancer (NSCLC)
Treatment options for NSCLC differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Lobectomy: Elimination of a lung lobe. The most popular procedure for NSCLC in its early stages is this one.
Pneumonectomy: Removal of a lung in its whole. If the cancer is in an area of the lung where the entire organ needs to be removed, this procedure might be carried out.
Wedge Resection: This removes a little lung section with the tumor.
Segmentectomy: This is the Removal of a more prominent lung segment but not the entire lobe. Usually, this is applied to individuals with lung impairment or early-stage cancer.
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy. It may be used in combination with chemotherapy for Non-Small Cell Lung Cancer (NSCLC).
Targeted Therapy : Medication designed for particular forms of lung cancer is used in this treatment. Targeted therapy can locate and target specific cancer cells without endangering healthy cells.
Cost Start From USD 5500 - USD 54000Explore Options
Immunotherapy : This is typically advised for late-stage lung cancer, notably Stage IV NSCLC, as it triggers your body's immune system to target and eliminate cancer cells.
{immunotherapy}Chemotherapy : It uses medications that target lung cancer. It is among the most widely used therapies for NSCLC. Chemotherapy may be prescribed by your oncologist alone or in conjunction with other treatments.
Cost Start From USD 800 - USD 6000Explore Options
Clinical Evaluation
- Medical History and Physical Examination: Healthcare professionals assemble detailed information about symptoms, medical history and risk factors afterlooking at NSCLC symptoms.
Imaging Studies
- CT Scan
- Chest X-Ray
- MRI
- PET Scan
Biopsy
- Bronchoscopy
- Needle Biopsy
- Surgical Biopsy
Laboratory Tests
- Blood Tests
- Sputum Cytology
- Thoracentesis
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Lifestyle changes and modification
While lifestyle modifications like stress reduction, yoga, and meditation improve general well-being, dietary changes involving high-fiber meals, lean meats, and supplements boost nutrition. Long-term health is further enhanced by abstaining from alcohol and eating a balanced diet.
Speech and Swallowing Therapy
Patients with NSCLC may have trouble speaking or swallowing if the disease affects the mouth, throat, or digestive system. Speech therapists can help patients regain clarity in their speech and enhance their swallowing function.
Monitoring and follow-up
Schedule regular follow-up appointments with the oncologist to address complications, monitor recovery, and detect any signs of recurrence.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.
Instantly Connect with our Specialists
Hospitals for Non-Small Cell Lung Cancer (NSCLC) in United Arab Emirates
Zulekha Hospital Sharjah
Sharjah, United Arab Emirates
Zulekha Hospital Sharjah located in Sharjah, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:
- Zulekha Hospital Sharjah is present over a 290,000 square feet area.
- The hospital stands today with a bed capacity of 185.
- The hospital also has a Cardiac Catheterization Laboratory and radiology as well as laboratory services.
- There is an ICU and Neonatal ICUs.
- There are facilities for Dialysis and advanced technological applications such as Minimal Invasive surgeries.
- In Zulekha Hospital Sharjah Bariatric procedures, Joint Replacement, Specialised Cancer Care, Cardio Thoracic and Vascular Procedure, Plastic and Reconstructive Procedure are performed.
- It also specialises in Pediatric Cardiology, Pulmonology and Chest Diseases, etc.
- Teleconsultation services as well as an international patient care center with related assistance for medical travelers are functioning in Zulekha Sharjah.
Burjeel Medical City
Abu Dhabi, United Arab Emirates
The Hospital owns an International Patient Services Team that is responsible to assist international patients with world-class healthcare, transportation arrangement, accommodation facilities, language interpreters, and much more.
Burjeel Medical City (about 1.2 million square facilities)provides 7-star hospitality to its patients. It has the largest facility space bed among all the private hospitals. The Hospital consists of-
- Large waiting areas and consultation rooms
- Spacious lobbies on each floor
- 338 Luxurious Patient Rooms
- 70 Ambulatory Rooms
- Intensive Care Units
- The Hospital comprises various centers, under Burjeel Cancer Institute-
- Breast Center
- Uro-oncology Center
- Surface Malignancy Center (HIPC)
- Head & Oncology Center
- Medical Oncology & Hematology Center and others
Zulekha Hospital Dubai
Dubai, United Arab Emirates
Zulekha Hospital Dubai located in Dubai, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:
- The bed capacity of Zulekha Hospital Dubai is 140.
- Diagnostic centers, pharmacies, inpatient and outpatient care are provided at Zulekha Hospital Dubai.
- This hospital provides the best of healthcare packages
- Its surgical base is really strong with the hospital having successfully initiated and completed minimally invasive surgeries, joint replacement surgeries, bariatric surgeries, cardiac, and neonatal surgeries.
- Radiology, laboratory, operating theatres, dialysis section and Cardiac Catheterization Laboratory are all present in Zulekha Hospital Dubai, UAE.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose the United Arab Emirates for Non-Small Cell Lung Cancer (NSCLC) Treatment?
- World-Class Healthcare Facilities: The UAE's modern hospitals and medical facilities have the newest technologies to spot and treat rare cancers like Non-Small Cell Lung Cancer (NSCLC).
- Affordable Treatment: The UAE offers Non-Small Cell Lung Cancer (NSCLC) treatment at a substantially lower cost than many Western nations without sacrificing care quality. Patients who receive top-notch care should anticipate significant cost reductions on everything from surgeries to cutting-edge treatments like radiation, surgeries and chemotherapy.
- Comprehensive Treatment Options: The UAE provides a holistic approach to treating Non-Small Cell Lung Cancer (NSCLC), including radiation therapy, Chemotherapy and surgical resection. New developments like gene treatments and tailored therapy are becoming more widely available to treat NSCLC better.
- Advanced Diagnostic Tools: Advanced diagnostic treatments like Lobectomy, Pneumonectomy, Wedge Resection, and Segmentectomyare available in the UAE hospitals to ensure precise diagnosis and treatment planning.
- Post-Treatment and Rehabilitation Care: Patients with NSCLC can receive complete rehabilitation programs in the UAE, including mental support, dietary counselling, and physical therapy. Patients who receive ongoing care and follow-up services are guaranteed access to the emotional support and monitoring they require while recovering.
Frequently Asked Questions
In the UAE, recovery times following therapy for non-small cell lung cancer (NSCLC) vary depending on the type of treatment, the features of the tumour, and the patient's health. Recovery from other therapies, such as chemotherapy or radiation, can take anything from a few weeks to several months, whereas recovery from surgery may take between 6 to 12 weeks.
In the UAE, it is customary practice to get a second opinion. Many hospitals and oncologists are willing to assess cases and offer second opinions on treatment strategies. One can:
- Forward pathology reports, imaging, and medical records to the hospital for evaluation.
- Set up a consultation with the specialist you choose, either in person or via teleconference.
- For NSCLC, major hospitals frequently have a team of experts who may offer a second opinion on the optimal treatment plan.
- You can get support by speaking with a medical tourism facilitator at MediGence to select the best doctor and facility. It provides specialised rehabilitation programs.
For patients with non-small cell lung cancer (NSCLC), post-treatment care in the United Arab Emirates entails routine follow-up visits with physical examinations and chest CT scans every 3-6 months for the first 2-3 years, then every six months for the next 2 years, and then annually after that.
Yes, even after a successful course of treatment, non-small cell lung cancer (NSCLC) might return. The type of treatment received, the patient's response to the treatment, and the stage of the cancer at diagnosis all affect the chance of recurrence.
In the UAE, the prognosis for individuals with non-small cell lung cancer (NSCLC) varies according to the cancer stage at diagnosis, general health, and response to treatment. Early identification and sophisticated treatment options available in the UAE can enhance survival chances.
Non-small cell lung cancer (NSCLC) is the sixth most prevalent cancer overall in the United Arab Emirates, making it comparatively rare.
The UAE is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs compared to several Western nations.
The UAE's healthcare system accepts patients from abroad and provides excellent NSCLS treatments at many clinics and hospitals.
Yes, many UAE hospitals offer in-person and online consultations to foreign patients who want a second opinion. You can get support by speaking with a medical tourism facilitator at MediGence to select the best doctor and facility. It provides specialised rehabilitation programs.